Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. REGN
2. CRWD
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. TFII
9. LYB
10. RXRX

Go back to Merck (MRK), Cubist (CBST) Deal Likely to Go Ahead Despite Unfavorable Litigation, Says RBC

Merck (MRK) on Watch as Takeover Target Cubist Pharma (CBST) Losses Patent Decision

December 8, 2014 5:20 PM EST

Merck (NYSE: MRK) is on watch on news today's takeover target Cubist Pharma (NASDAQ: CBST) lost a bid to prevent Hospira (NYSE: HSP) from making generic Cubicin.

Merck likely fully... More

Cubist Pharma (CBST) Declines: Traders Discuss Patent Dispute vs Hospira (HSP)

December 8, 2014 5:11 PM EST

(Updated - December 8, 2014 5:21 PM EST)

Cubist Pharma (NASDAQ: CBST) declined after-hours Monday. Traders discussed comments from Evercore ISI related to a patent dispute with Hospira (NYSE: HSP). Below is a tweet from CNBC's Meg... More